Abstract:Proper protein arginine methylation by protein arginine methyltransferase 1 (PRMT1) is critical for maintaining cellular health, while dysregulation is often associated with disease. How the activity of PRMT1 is regulated is therefore paramount, but is not clearly understood. Several studies have observed higher order oligomeric species of PRMT1, but it is unclear if these exist at physiological concentrations and there is confusion in the literature about how oligomerization affects activity. We therefore sought to determine which oligomeric species of PRMT1 are physiologically relevant, and quantitatively correlate activity with specific oligomer forms. Through quantitative western blotting, we determined that concentrations of PRMT1 available in a variety of human cell lines are in the sub‐micromolar to low micromolar range. Isothermal spectral shift binding data were modeled to a monomer/dimer/tetramer equilibrium with an EC50 for tetramer dissociation of ~20 nM. A combination of sedimentation velocity and Native polyacrylamide gel electrophoresis experiments directly confirmed that the major oligomeric species of PRMT1 at physiological concentrations would be dimers and tetramers. Surprisingly, the methyltransferase activity of a dimeric PRMT1 variant is similar to wild type, tetrameric PRMT1 with some purified substrates, but dimer and tetramer forms of PRMT1 show differences in catalytic efficiencies and substrate specificity for other substrates. Our results define an oligomerization paradigm for PRMT1, show that the biophysical characteristics of PRMT1 are poised to support a monomer/dimer/tetramer equilibrium in vivo, and suggest that the oligomeric state of PRMT1 could be used to regulate substrate specificity.

Crystal structure of the human PRMT5:MEP50 complex

The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond

Molecular basis for substrate recruitment to the PRMT5 methylosome

Substrate Specificity, Processivity, and Kinetic Mechanism of Protein Arginine Methyltransferase 5

Cryo-EM Structures of Human M6a Writer Complexes

Molecular Mechanism underlying PRMT1 Dimerization for SAM Binding and Methylase Activity

The Structure and Functions of PRMT5 in Human Diseases

Oligomerization of protein arginine methyltransferase 1 and its effect on methyltransferase activity and substrate specificity

Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)

Proteomics Profiling of Arginine Methylation Defines PRMT5 Substrate Specificity

Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders

Crystal structure of arginine methyltransferase 6 from Trypanosoma brucei.

Structural determinants for the strict monomethylation activity by trypanosoma brucei protein arginine methyltransferase 7.

Structural Insights Into Protein Arginine Symmetric Dimethylation By Prmt5

The Where and the How of PRMT5

Discovery of a Dual PRMT5–PRMT7 Inhibitor

ETD-Based Proteomic Profiling Improves Arginine Methylation Identification and Reveals Novel PRMT5 Substrates

Oligomerization of PRMT1 Regulated RNA-Binding Protein Cascade Promotes Pancreatic Ductal Adenocarcinoma

Medicinal chemistry insights into PRMT5 inhibitors

Crystal structure of tRNA m1G9 methyltransferase Trm10: insight into the catalytic mechanism and recognition of tRNA substrate.

Theoretical insights into catalytic mechanism of protein arginine methyltransferase 1